血管化复合组织异体移植中的体外灌注:当前概念与未来前景
面部与肢体严重缺损修复仍是重建外科难题,血管化复合组织异体移植(VCA)受限于移植物可耐受缺血时间短和免疫原性强两大障碍。本文综述实体器官移植临床机器灌注策略及实验性VCA灌注研究,讨论温度、氧合、流型、灌注液及添加剂的优化设置,并展望机器灌注成功引入临床后对VCA作为整形外科治疗手段的意义。
要点
- VCA面临两大限制:移植物可耐受缺血时间有限使供体半径极小,以及移植物免疫原性强需终身监测和免疫抑制治疗。
- 机器灌注在实体器官移植中已显示可延长缺血时间并降低免疫原性的临床成功。
- 尽管近期多项临床前试验有前景,机器灌注尚未在临床VCA中应用。
核心结论
- 机器灌注在实体器官移植中已获临床成功,但尚未用于临床VCA;若能在临床环境中成功引入,将影响VCA作为整形外科治疗手段的效用。
研究设计与样本
- 综述,呈现临床实体器官移植和实验性VCA的最新灌注策略,并依据血管化复合移植物的独特组织构成讨论温度、氧合、流型、灌注液及最有前景添加剂的优化设置。
主要发现
- VCA的两项关键限制为移植物可耐受缺血时间有限使潜在供体半径极小,以及移植物免疫原性强使广泛终身监测和免疫抑制治疗成为必需。
- 机器灌注系统通过延长可耐受缺血时间和降低免疫原性,在实体器官移植中已显示临床成功。
- 尽管近期多项临床前试验有前景,机器灌注尚未在临床VCA中应用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe injuries of the face and limbs remain a major challenge in today's reconstructive surgery. Vascularized composite allotransplantation (VCA) has emerged as a promising approach to restore these defects. Yet, there are major obstacles preventing VCA from broad clinical application. Two key restrictions are (1) the graft's limited possible ischemia time, keeping the potential donor radius extremely small, and (2) the graft's immunogenicity, making extensive lifelong monitoring and immunosuppressive treatment mandatory. Machine perfusion systems have demonstrated clinical success addressing these issues in solid organ transplantation by extending possible ischemia times and decreasing immunogenicity. Despite many recent promising preclinical trials, machine perfusion has not yet been utilized in clinical VCA. This review presents latest perfusion strategies in clinical solid organ transplantation and experimental VCA in light of the specific requirements by the vascularized composite allograft's unique tissue composition. It discusses optimal settings for temperature, oxygenation, and flow types, as well as perfusion solutions and the most promising additives. Moreover, it highlights the implications for the utility of VCA as therapeutic measure in plastic surgery, if machine perfusion can be successfully introduced in a clinical setting.
引用
- Kueckelhaus M, Puscz F, Dermietzel A, et al. Extracorporeal Perfusion in Vascularized Composite Allotransplantation: Current Concepts and Future Prospects. Ann Plast Surg. 2018. PMID: 29746324. doi:10.1097/SAP.0000000000001477
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。